Predictions
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.35
15.03.21
15.03.21
€50.00
15.03.22
15.03.22
43.43%
09.11.21
09.11.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Johnson & Johnson
Start price
Target price
Perf. (%)
€137.96
08.02.21
08.02.21
€160.00
08.02.22
08.02.22
8.94%
08.02.22
08.02.22
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€271.85
08.02.21
08.02.21
-
08.02.22
08.02.22
-1.91%
20.02.21
20.02.21
Johnson & Johnson
Start price
Target price
Perf. (%)
€138.90
05.02.21
05.02.21
-
31.12.21
31.12.21
0.09%
29.03.21
29.03.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€274.60
29.01.21
29.01.21
€300.00
29.01.22
29.01.22
52.59%
30.01.22
30.01.22
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€282.25
28.01.21
28.01.21
€350.00
28.01.22
28.01.22
22.16%
02.07.21
02.07.21
Johnson & Johnson
Start price
Target price
Perf. (%)
€134.68
20.01.21
20.01.21
€144.00
0.89%
02.02.21
02.02.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Johnson & Johnson
Start price
Target price
Perf. (%)
€132.40
14.01.21
14.01.21
€144.00
14.01.22
14.01.22
10.89%
15.01.22
15.01.22
Johnson & Johnson
Start price
Target price
Perf. (%)
€125.32
28.12.20
28.12.20
€140.00
28.12.21
28.12.21
20.17%
29.12.21
29.12.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.01
18.12.20
18.12.20
€34.00
18.12.21
18.12.21
-5.35%
15.03.21
15.03.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.91
17.12.20
17.12.20
€29.00
-1.81%
21.12.20
21.12.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€273.65
16.12.20
16.12.20
-
16.12.21
16.12.21
-0.75%
23.02.21
23.02.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€35.01
12.12.20
12.12.20
-
12.12.21
12.12.21
-14.23%
24.03.21
24.03.21
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies